News & Events

Retia Medical Announces Partnership with TekUS For International Market Outreach

June 27, 2019

Valhalla, NY – June 27, 2019 – Retia Medical, LLC, a medical device company focused on transforming the practice of critical care by making accurate hemodynamic data available and affordable for use at every bed, today announced the joining of efforts with TekUS, based in Atlanta, Georgia.  Marc Zemel, Retia Medical’s CEO states “Critically ill patients in every part of the world should have access to this important technology and we are excited to begin this partnership with TekUS to deliver our   innovative technology to the Gulf Coast countries and parts of India.” Billy D. Williams, President of TekUS, describes: “TekUS is a Master Distributor focused on bringing clinically superior medical technologies made in the USA to the international market”. “In our many years of medical device experience we find that most exciting new technologies originate in startup companies.” Their focus is to help these medical companies expand internationally by providing efficient and cost-effective marketing support.

TekUS’ goal is to improve the way healthcare is provided by focusing on products that provide: 

  • Reduce length of stay (LOS)
  • Reduce time required to perform a procedure
  • Improve patient safety
  • Reduce technical difficulty in using a technology
  • Improve accuracy
  • Reduce cost
  • Reduce infection risk


Billy Williams further states “We are excited about our relationship with Retia and the new Argos CO monitor, which is the first device that fulfils all of our target benefits. We believe the Argos CO Monitor’s ease of use and cost effectiveness will enable clinicians to monitor more patients with improved accuracy resulting in shorter LOS and increased patient safety.”


About the Argos Cardiac Output Monitor

Retia Medical designed the Argos Cardiac Output (CO) Monitor to provide members of the Critical Care team in the operating room and intensive care unit with a more accurate, intuitive and affordable hemodynamic monitor that supports confident, data-driven patient care decision making.

Equipped with Retia’s proprietary MBA™ algorithm, which uses advanced signal processing to improve the model of circulation and enables accurate tracking of both fluid and pressor resuscitation, the Argos Monitor seamlessly combines accuracy, ease of use, EMR connectivity and cost-effectiveness.

 About Retia Medial

Retia Medical aims to advance the use of CO monitoring to improve patient care by providing members of the critical care team with a more accurate, easy-to-use, and affordable hemodynamic monitor that supports confident, data-based decisions.

Retia brings together industry-leading expertise in physiology, signal processing, and computational algorithms to engineer innovative monitoring solutions that give clinicians up-to-the-minute data that they can rely on to make informed patient care decisions. Additionally, Retia is committed to offering more clinicians access to CO monitoring by reducing the cost and inconvenience that limit the use of traditional CO technologies to the most high-risk patients. For additional information, please visit


Corporate Contact
Jayne Peister
(914) 594-1986